These are anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).
The ulcerative colitis drugs market is segmented based on type, application, and geography. On the basis of type, ulcerative colitis drugs market divided into xxxx. Further, the ulcerative colitis drugs market is segmented by application into xxxx. Geographically, the ulcerative colitis drugs market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.
The key market players operating in the ulcerative colitis drugs market include Johnson & Johnson, AbbVie, Takeda Pharmaceuticals, Roche, Warner Chilcott, Salix Pharmaceuticals/Santarus, Shire Pharmaceuticals, Ferring Pharmaceuticals, Pfizer, and InDeX Pharmaceuticals among others.
ULCERATIVE COLITIS DRUGS MARKET SEGMENTS
Market By Type
• Oral
• Injection
Market By Application
• Hospital
• Drugs Stores
Market By Geography
• North America
• Europe
• Asia-Pacific
• Rest of the world
Key Players
• Johnson & Johnson
• AbbVie
• Takeda Pharmaceuticals
• Roche
• Warner Chilcott
• Salix Pharmaceuticals/Santarus
• Shire Pharmaceuticals
• Ferring Pharmaceuticals
• Pfizer
• InDeX Pharmaceuticals
Executive Summary
1 Ulcerative Colitis Market Overview
1.1 Product Overview and Scope of Ulcerative Colitis
1.2 Ulcerative Colitis Segment by Type
1.2.1 Global Ulcerative Colitis Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Oral
1.2.3 Injection
1.3 Ulcerative Colitis Segment by Application
1.3.1 Ulcerative Colitis Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Ulcerative Colitis Market by Region
1.4.1 Global Ulcerative Colitis Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Ulcerative Colitis Market Size
1.5.1 Global Ulcerative Colitis Revenue (2014-2025)
1.5.2 Global Ulcerative Colitis Production (2014-2025)
2 Global Ulcerative Colitis Market Competition by Manufacturers
2.1 Global Ulcerative Colitis Production Market Share by Manufacturers (2014-2019)
2.2 Global Ulcerative Colitis Revenue Share by Manufacturers (2014-2019)
2.3 Global Ulcerative Colitis Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Ulcerative Colitis Production Sites, Area Served, Product Types
2.5 Ulcerative Colitis Market Competitive Situation and Trends
2.5.1 Ulcerative Colitis Market Concentration Rate
2.5.2 Ulcerative Colitis Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Ulcerative Colitis Production Market Share by Regions
3.1 Global Ulcerative Colitis Production Market Share by Regions
3.2 Global Ulcerative Colitis Revenue Market Share by Regions (2014-2019)
3.3 Global Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Ulcerative Colitis Production
3.4.1 North America Ulcerative Colitis Production Growth Rate (2014-2019)
3.4.2 North America Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Ulcerative Colitis Production
3.5.1 Europe Ulcerative Colitis Production Growth Rate (2014-2019)
3.5.2 Europe Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Ulcerative Colitis Production (2014-2019)
3.6.1 China Ulcerative Colitis Production Growth Rate (2014-2019)
3.6.2 China Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Ulcerative Colitis Production (2014-2019)
3.7.1 Japan Ulcerative Colitis Production Growth Rate (2014-2019)
3.7.2 Japan Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Ulcerative Colitis Consumption by Regions
4.1 Global Ulcerative Colitis Consumption by Regions
4.2 North America Ulcerative Colitis Consumption (2014-2019)
4.3 Europe Ulcerative Colitis Consumption (2014-2019)
4.4 China Ulcerative Colitis Consumption (2014-2019)
4.5 Japan Ulcerative Colitis Consumption (2014-2019)
5 Global Ulcerative Colitis Production, Revenue, Price Trend by Type
5.1 Global Ulcerative Colitis Production Market Share by Type (2014-2019)
5.2 Global Ulcerative Colitis Revenue Market Share by Type (2014-2019)
5.3 Global Ulcerative Colitis Price by Type (2014-2019)
5.4 Global Ulcerative Colitis Production Growth by Type (2014-2019)
6 Global Ulcerative Colitis Market Analysis by Applications
6.1 Global Ulcerative Colitis Consumption Market Share by Application (2014-2019)
6.2 Global Ulcerative Colitis Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Ulcerative Colitis Business
7.1 Johnson & Johnson.
7.1.1 Johnson & Johnson. Ulcerative Colitis Production Sites and Area Served
7.1.2 Ulcerative Colitis Product Introduction, Application and Specification
7.1.3 Johnson & Johnson. Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 AbbVie
7.2.1 AbbVie Ulcerative Colitis Production Sites and Area Served
7.2.2 Ulcerative Colitis Product Introduction, Application and Specification
7.2.3 AbbVie Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Takeda Pharmaceuticals
7.3.1 Takeda Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
7.3.2 Ulcerative Colitis Product Introduction, Application and Specification
7.3.3 Takeda Pharmaceuticals Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Roche
7.4.1 Roche Ulcerative Colitis Production Sites and Area Served
7.4.2 Ulcerative Colitis Product Introduction, Application and Specification
7.4.3 Roche Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Warner Chilcott
7.5.1 Warner Chilcott Ulcerative Colitis Production Sites and Area Served
7.5.2 Ulcerative Colitis Product Introduction, Application and Specification
7.5.3 Warner Chilcott Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Salix Pharmaceuticals/Santarus
7.6.1 Salix Pharmaceuticals/Santarus Ulcerative Colitis Production Sites and Area Served
7.6.2 Ulcerative Colitis Product Introduction, Application and Specification
7.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Shire Pharmaceuticals
7.7.1 Shire Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
7.7.2 Ulcerative Colitis Product Introduction, Application and Specification
7.7.3 Shire Pharmaceuticals Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Ferring Pharmaceuticals
7.8.1 Ferring Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
7.8.2 Ulcerative Colitis Product Introduction, Application and Specification
7.8.3 Ferring Pharmaceuticals Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Pfizer
7.9.1 Pfizer Ulcerative Colitis Production Sites and Area Served
7.9.2 Ulcerative Colitis Product Introduction, Application and Specification
7.9.3 Pfizer Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 InDeX Pharmaceuticals
7.10.1 InDeX Pharmaceuticals Ulcerative Colitis Production Sites and Area Served
7.10.2 Ulcerative Colitis Product Introduction, Application and Specification
7.10.3 InDeX Pharmaceuticals Ulcerative Colitis Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
8 Ulcerative Colitis Manufacturing Cost Analysis
8.1 Ulcerative Colitis Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Ulcerative Colitis
8.4 Ulcerative Colitis Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Ulcerative Colitis Distributors List
9.3 Ulcerative Colitis Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Ulcerative Colitis Market Forecast
11.1 Global Ulcerative Colitis Production, Revenue Forecast
11.1.1 Global Ulcerative Colitis Production Growth Rate Forecast (2019-2025)
11.1.2 Global Ulcerative Colitis Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Ulcerative Colitis Price and Trend Forecast (2019-2025)
11.2 Global Ulcerative Colitis Production Forecast by Regions (2019-2025)
11.2.1 North America Ulcerative Colitis Production, Revenue Forecast (2019-2025)
11.2.2 Europe Ulcerative Colitis Production, Revenue Forecast (2019-2025)
11.2.3 China Ulcerative Colitis Production, Revenue Forecast (2019-2025)
11.2.4 Japan Ulcerative Colitis Production, Revenue Forecast (2019-2025)
11.3 Global Ulcerative Colitis Consumption Forecast by Regions (2019-2025)
11.3.1 North America Ulcerative Colitis Consumption Forecast (2019-2025)
11.3.2 Europe Ulcerative Colitis Consumption Forecast (2019-2025)
11.3.3 China Ulcerative Colitis Consumption Forecast (2019-2025)
11.3.4 Japan Ulcerative Colitis Consumption Forecast (2019-2025)
11.4 Global Ulcerative Colitis Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Ulcerative Colitis Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
© 2019 Data N Analysis. All Rights Reserved | Design by Data N Analysis